IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 31.512

Change

-0.11 (-0.35)%

Market Cap

N/A

Volume

1.70K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.11 (-0.59%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.70 (-1.22%)

USD 40.21B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 35.73B
DFAC Dimensional U.S. Core Equity 2..

-0.65 (-1.94%)

USD 32.11B
JPST JPMorgan Ultra-Short Income ET..

+0.03 (+0.06%)

USD 30.68B
DTB DTE Energy Company 2020 Series

-0.07 (-0.38%)

USD 26.58B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 21.88B
GBTC Grayscale Bitcoin Trust (BTC)

-2.62 (-3.81%)

USD 16.99B
AVUV Avantis® U.S. Small Cap Value..

-1.81 (-2.04%)

USD 15.35B
CGDV Capital Group Dividend Value E..

-0.64 (-1.77%)

USD 15.10B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.93% 23% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.93% 23% F 30% F
Trailing 12 Months  
Capital Gain -0.50% 27% F 39% F
Dividend Return 0.53% 10% F 8% B-
Total Return 0.03% 20% F 31% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.07% 75% C 58% F
Dividend Return 7.49% 74% C 52% F
Total Return 0.42% 24% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 9.22% 54% F 81% B-
Risk Adjusted Return 81.27% 83% B 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.